Skip to Main Content

Paper Details

Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy.
BMJ Open
1
2021
PCV, aflibercept, indocyanine green, patients, polypoidal choroidal vasculopathy
Author NameAffiliation
Chui Ming Gemmy CheungSingapore Eye Research Institute
Chui Ming Gemmy Cheung
Tien Yin WongSingapore Eye Research Institute
Tien Yin Wong
Tien Yin WongSingapore Eye Research Institute
Tien Yin Wong
Kelvin Yi Chong TeoSingapore Eye Research Institute
Kelvin Yi Chong Teo
  • 1 - 8

Datasets

Release 1.2